<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Emerg Infect Dis</journal-id><journal-id journal-id-type="pmc">eid</journal-id><journal-title>Emerging Infectious Diseases</journal-title><issn pub-type="ppub">1080-6040</issn><issn pub-type="epub">1080-6059</issn><publisher><publisher-name>Centers for Disease Control</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">10221882</article-id><article-id pub-id-type="pmc">2640695</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Evaluating diagnosis and treatment of oral and esophageal candidiasis in Ugandan AIDS patients.</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ravera</surname><given-names>M.</given-names></name><email>petra@swiftuganda.com</email></contrib><contrib contrib-type="author"><name><surname>Reggiori</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Agliata</surname><given-names>A. M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Rocco</surname><given-names>R. P.</given-names></name></contrib></contrib-group><aff>Regional Teaching Hospital, Hoima, Uganda.</aff><pub-date pub-type="ppub"><season>Mar-Apr</season><year>1999</year></pub-date><volume>5</volume><issue>2</issue><fpage>274</fpage><lpage>277</lpage><abstract><p>A randomized cross-over clinical and endoscopic evaluation of 85 Ugandan patients showed that esophageal candidiasis in AIDS patients with oral candidiasis could be managed without endoscopy and biopsies. Oral lesions, especially when accompanied by esophageal symptoms, were sufficient for diagnosis. Miconazole was more effective than nystatin in treating esophageal candidiasis and could be a valid alternative to more expensive azolic drugs in developing countries.</p></abstract></article-meta></front></article>

